Improving the prescription of folate to women receiving antiepileptic drugs

Epilepsy Research

Volumn 112, Issue , 2015, Pages 27-30

  Sharma, Anumeha ^a,b   Cavitt, Jennifer ^a,b   Privitera, Michael ^a,b   Moseley, Brian D ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

Antiepileptic drug side effects; Fetal malformations; Pregnancy and epilepsy; Teratogenesis; Women and epilepsy

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; ETIRACETAM; FOLIC ACID; GABAPENTIN; HARKOSERIDE; LAMOTRIGINE; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; PREGABALIN; TOPIRAMATE; VALPROIC ACID; ZONISAMIDE; VITAMIN B COMPLEX;

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DRUG SAFETY; EPILEPSY; FEMALE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; NAMED GROUPS OF PERSONS; NEUROLOGIC DISEASE; NEUROLOGIST; PATIENT COMPLIANCE; PATIENT EDUCATION; PRESCRIPTION; PRIORITY JOURNAL; RISK REDUCTION; TERATOGENICITY; WOMEN OF CHILDBEARING POTENTIAL; FOLLOW UP; PREGNANCY;

ADULT; ANTICONVULSANTS; EPILEPSY; FEMALE; FOLIC ACID; FOLLOW-UP STUDIES; HUMANS; PREGNANCY; PRESCRIPTIONS; VITAMIN B COMPLEX;

EID: 84926321699     PISSN: 09201211     EISSN: 18726844     Source Type: Journal    
DOI: 10.1016/j.eplepsyres.2015.02.004     Document Type: Article

References (15)

1. Christensen J., Gronborg T.K., Sorensen M.J., Schendel D., Parner E.T., Pedersen L.H., Vestergaard M. Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism. JAMA 2013, 309:1696-1703.
2. D'Amico D. Antiepileptic drugs in the prophylaxis of migraine, chronic headache forms and cluster headache: a review of their efficacy and tolerability. Neurol. Sci. 2007, 28(Suppl. 2):S188-S197.
3. Finer L.B., Zolna M.R. Unintended pregnancy in the United States: incidence and disparities, 2006. Contraception 2011, 84:478-485.
4. Hansen D.K., Billings R.E. Phenytoin teratogenicity and effects on embryonic and maternal folate metabolism. Published erratum appears in Teratology 1986;34 December (3):487. Teratology 1985, 31:363-371.
5. Harden C.L., Pennell P.B., Koppel B.S., Hovinga C.A., Gidal B., Meador K.J., Hopp J., Ting T.Y., Hauser W.A., Thurman D., Kaplan P.W., Robinson J.N., French J.A., Wiebe S., Wilner A.N., Vazquez B., Holmes L., Krumholz A., Finnell R., Shafer P.O., Le Guen C.L., American Academy of Neurology, American Epilepsy Society Management issues for women with epilepsy - focus on pregnancy (an evidence-based review): III. Vitamin K, folic acid, blood levels, and breast-feeding: report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Epilepsia 2009, 50:1247-1255.
6. Hauser W.A., Annegers J.F., Kurland L.T. Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota: 1935-1984. Epilepsia 1993, 34:453-468.
7. Hernandez-Diaz S., Werler M.M., Walker A.M., Mitchell A.A. Folic acid antagonists during pregnancy and the risk of birth defects. N. Engl. J. Med. 2000, 343:1608-1614.
8. Julvez J., Fortuny J., Mendez M., Torrent M., Ribas-Fito N., Sunyer J. Maternal use of folic acid supplements during pregnancy and four-year-old neurodevelopment in a population-based birth cohort. Paediatr. Perinat. Epidemiol. 2009, 23:199-206.
9. Kwan P., Brodie M.J. Early identification of refractory epilepsy. N. Engl. J. Med. 2000, 342:314-319.
10. Lipton R.B., Stewart W.F., Diamond S., Diamond M.L., Reed M. Prevalence and burden of migraine in the United States: data from the American Migraine Study II. Headache 2001, 41:646-657.
11. Meador K.J., Baker G.A., Browning N., Cohen M.J., Bromley R.L., Clayton-Smith J., Kalayjian L.A., Kanner A., Liporace J.D., Pennell P.B., Privitera M., Loring D.W. Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study): a prospective observational study. Lancet Neurol. 2013, 12:244-252. NEAD Study Group.
12. Roth C., Magnus P., Schjolberg S., Stoltenberg C., Suren P., McKeague I.W., Davey Smith G., Reichborn-Kjennerud T., Susser E. Folic acid supplements in pregnancy and severe language delay in children. JAMA 2011, 306:1566-1573.
13. Tamura T., Goldenberg R.L., Chapman V.R., Johnston K.E., Ramey S.L., Nelson K.G. Folate status of mothers during pregnancy and mental and psychomotor development of their children at five years of age. Pediatrics 2005, 116:703-708.
14. U.S.Preventive Services Task Force Folic acid for the prevention of neural tube defects: U.S. Preventive Services Task Force recommendation statement. Ann. Intern. Med. 2009, 150:626-631.
15. Wehby G.L., Murray J.C. The effects of prenatal use of folic acid and other dietary supplements on early child development. Matern. Child Health J. 2008, 12:180-187.